CCL28 Has Dual Roles in Mucosal Immunity as a Chemokine with Broad-Spectrum Antimicrobial Activity 1

CCL28 is a CC chemokine signaling via CCR10 and CCR3 that is selectively expressed in certain mucosal tissues such as exocrine glands, trachea, and colon. Notably, these tissues commonly secrete low-salt fluids. RT-PCR analysis demonstrated that salivary glands expressed CCL28 mRNA at the highest levels among various mouse tissues. Single cells prepared from mouse parotid glands indeed contained a major fraction of CD3−B220low cells that expressed CCR10 at high levels and CCR3 at low levels and responded to CCL28 in chemotaxis assays. Morphologically, these cells are typical plasma cells. By immunohistochemistry, acinar epithelial cells in human and mouse salivary glands were strongly positive for CCL28. Furthermore, human saliva and milk were found to contain CCL28 at high concentrations. Moreover, the C terminus of human CCL28 has a significant sequence similarity to histatin-5, a histidine-rich candidacidal peptide in human saliva. Subsequently, we demonstrated that human and mouse CCL28 had a potent antimicrobial activity against Candida albicans, Gram-negative bacteria, and Gram-positive bacteria. The C-terminal 28-aa peptide of human CCL28 also displayed a selective candidacidal activity. In contrast, CCL27, which is most similar to CCL28 and shares CCR10, showed no such potent antimicrobial activity. Like most other antimicrobial peptides, CCL28 exerted its antimicrobial activity in low-salt conditions and rapidly induced membrane permeability in target microbes. Collectively, CCL28 may play dual roles in mucosal immunity as a chemoattractant for cells expressing CCR10 and/or CCR3 such as plasma cells and also as a broad-spectrum antimicrobial protein secreted into low-salt body fluids.

[1]  L. Kwak,et al.  Mammalian defensins in immunity: more than just microbicidal. , 2002, Trends in immunology.

[2]  A. Imberty,et al.  Structural diversity of heparan sulfate binding domains in chemokines , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Zasloff Antimicrobial peptides of multicellular organisms , 2002, Nature.

[4]  Takaaki Ohtake,et al.  Innate antimicrobial peptide protects the skin from invasive bacterial infection , 2001, Nature.

[5]  H. Iwamoto,et al.  Characterization of the metal-substituted dipeptidyl peptidase III (rat liver). , 2001, Biochemistry.

[6]  J. Lieberman,et al.  Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. , 2001, The Journal of clinical investigation.

[7]  M. Burdick,et al.  Cutting Edge: IFN-Inducible ELR− CXC Chemokines Display Defensin-Like Antimicrobial Activity1 , 2001, The Journal of Immunology.

[8]  J. Cyster,et al.  A Coordinated Change in Chemokine Responsiveness Guides Plasma Cell Movements , 2001, The Journal of experimental medicine.

[9]  O. Chertov,et al.  The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity , 2001, Cellular and Molecular Life Sciences CMLS.

[10]  R. Hancock,et al.  Synergistic Interactions between Mammalian Antimicrobial Defense Peptides , 2001, Antimicrobial Agents and Chemotherapy.

[11]  K. Matsushima,et al.  Macrophage-derived chemokine (MDC/CCL22) and CCR4 are involved in the formation of T lymphocyte-dendritic cell clusters in human inflamed skin and secondary lymphoid tissue. , 2001, The American journal of pathology.

[12]  T. Abee,et al.  Characterization of Histatin 5 with Respect to Amphipathicity, Hydrophobicity, and Effects on Cell and Mitochondrial Membrane Integrity Excludes a Candidacidal Mechanism of Pore Formation* , 2001, The Journal of Biological Chemistry.

[13]  T. Tezuka,et al.  Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3 alpha/CCL20 by epidermal keratinocytes and its role in atopic dermatitis. , 2001, International immunology.

[14]  Kathleen M. Smith,et al.  Identification of a Novel Chemokine (CCL28), which Binds CCR10 (GPR2)* , 2000, The Journal of Biological Chemistry.

[15]  J. Krijgsveld,et al.  Thrombocidins, Microbicidal Proteins from Human Blood Platelets, Are C-terminal Deletion Products of CXC Chemokines* , 2000, The Journal of Biological Chemistry.

[16]  G. Graham,et al.  Cutting Edge: Identification of the Orphan Receptor G-Protein-Coupled Receptor 2 as CCR10, a Specific Receptor for the Chemokine ESkine1 2 , 2000, The Journal of Immunology.

[17]  Weiqi Wang,et al.  Cutting Edge: The Orphan Chemokine Receptor G Protein-Coupled Receptor-2 (GPR-2, CCR10) Binds the Skin-Associated Chemokine CCL27 (CTACK/ALP/ILC)1 , 2000, The Journal of Immunology.

[18]  A. Zlotnik,et al.  Chemokines: a new classification system and their role in immunity. , 2000, Immunity.

[19]  N. Copeland,et al.  CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Suzuki,et al.  Molecular cloning of a novel CC chemokine, interleukin‐11 receptor α‐locus chemokine (ILC), which is located on chromosome 9p13 and a potential homologue of a CC chemokine encoded by molluscum contagiosum virus , 1999, FEBS letters.

[21]  Ji Ming Wang,et al.  β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6 , 1999 .

[22]  A. Grottesi,et al.  Zn(2+) ions selectively induce antimicrobial salivary peptide histatin-5 to fuse negatively charged vesicles. Identification and characterization of a zinc-binding motif present in the functional domain. , 1999, Biochemistry.

[23]  T. Abee,et al.  The Cellular Target of Histatin 5 on Candida albicans Is the Energized Mitochondrion* , 1999, The Journal of Biological Chemistry.

[24]  J. Isaacs,et al.  Therapy with monoclonal antibodies. II. The contribution of Fc gamma receptor binding and the influence of C(H)1 and C(H)3 domains on in vivo effector function. , 1998, Journal of immunology.

[25]  D. Taub,et al.  Identification of Defensin-1, Defensin-2, and CAP37/Azurocidin as T-cell Chemoattractant Proteins Released from Interleukin-8-stimulated Neutrophils (*) , 1996, The Journal of Biological Chemistry.

[26]  Tao Xu,et al.  Anticandidal activity of major human salivary histatins , 1991, Infection and immunity.

[27]  P. A. Raj,et al.  Salivary histatin 5: dependence of sequence, chain length, and helical conformation for candidacidal activity. , 1990, The Journal of biological chemistry.

[28]  T. Ganz,et al.  Monocyte-chemotactic activity of defensins from human neutrophils. , 1989, The Journal of clinical investigation.

[29]  S. Levitz,et al.  Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. , 1988, The Journal of biological chemistry.

[30]  C. Conner Therapy with Monoclonal Antibodies , 1984, Drug intelligence & clinical pharmacy.

[31]  H. Nomiyama,et al.  Chemokines in immunity. , 2001, Advances in immunology.

[32]  L. Schild,et al.  Structure function relationships of ENaC and its role in sodium handling. , 2001, Advances in experimental medicine and biology.

[33]  O. Gotoh,et al.  Multiple sequence alignment: algorithms and applications. , 1999, Advances in biophysics.

[34]  L. Bobek,et al.  Human salivary histatins: promising anti-fungal therapeutic agents. , 1998, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.